The Shepherd Foundation Study into Alzheimer's Disease

Phase 3

• Conditions: Mild to moderate Alzheimer's disease; Neurological - Alzheimer's disease

• Registration Number: ACTRN12606000324516
• Lead Sponsor: Melbourne Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-07-27
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Mild to moderate Alzheimer's disease (Mini mental state examination score of 12-24). The Alzheimer's disease was diagnosed by a specialist or specialist clinic. There may be co-existing cerebrovascular disease or Parkinsonism subject to the exclusion criteria. On stable dose anticholinesterase therapy for at least 3 months or off such therapy (because failed it or could not tolerate it) for at least 3 months. Conversant in English. Consent obtained.

Exclusion Criteria

Prominent dysphasia.Defined abnormalities/levels on screening blood tests.History of renal calculi.History of GIT lesions which may affect absorption of MKTVIF75HV.Febrile illness greater than one day and/or IVI antibiotics and/or intravenous sedation or general anaesthesia within one month prior to first cognitive assessment.Past cranial neurosurgery, epilepsy or multiple sclerosis. Type one diabetes. Lesions which may affect compliance with study regimen.

Study & Design

• Study Type: Interventional
• Study Design: Not specified